Last reviewed · How we verify
Vitamin D: solid form, start monthly
Vitamin D acts as a steroid hormone that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis, immune function, and cell differentiation.
Vitamin D acts as a steroid hormone that binds to the vitamin D receptor to regulate calcium and phosphate homeostasis, immune function, and cell differentiation. Used for Vitamin D deficiency, Hypocalcemia, Hypoparathyroidism.
At a glance
| Generic name | Vitamin D: solid form, start monthly |
|---|---|
| Also known as | Dekristol |
| Sponsor | University Hospital, Basel, Switzerland |
| Drug class | Vitamin/steroid hormone |
| Target | Vitamin D receptor (VDR) |
| Modality | Small molecule |
| Therapeutic area | Endocrinology/Bone metabolism/Immunology |
| Phase | FDA-approved |
Mechanism of action
Vitamin D (cholecalciferol or ergocalciferol) is converted in the liver and kidneys to its active form, calcitriol, which binds to the vitamin D receptor (VDR) in target tissues. This activation regulates intestinal calcium and phosphate absorption, bone mineralization, and immune cell function. It also modulates cell proliferation and differentiation across multiple tissues.
Approved indications
- Vitamin D deficiency
- Hypocalcemia
- Hypoparathyroidism
- Osteomalacia
- Rickets
Common side effects
- Hypercalcemia
- Hypercalciuria
- Nausea
- Vomiting
- Constipation
- Weakness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: